SCHEMBL20056037

SCHEMBL20056037

O=C(NCC1CCN(CCNP(O)C2CC2)CC1)c1ccc(F)c(C(F)(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CACNA1I Q9P0X4 8/20 0.48
KCNH2 Q12809 7/20 0.46
CACNA1H O95180 1/20 0.44
CYP2D6 P10635 1/20 0.44
TAS1R3 Q7RTX0 2/20 0.44
TAS1R1 Q7RTX1 2/20 0.44
TAS1R2 Q8TE23 2/20 0.44
KDM1A O60341 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HTR4 Q13639 1/20 0.43
CCR2 P41597 1/20 0.42
HTR7 P34969 1/20 0.42
MAPK14 Q16539 1/20 0.41
PLD2 O14939 2/20 0.40
PLD1 Q13393 2/20 0.40
BCHE P06276 1/20 0.40
MAOB P27338 1/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112773 0.85 CACNA1I (0.53) CACNA1IKCNH2CACNA1HCYP2D6TAS1R3
SCHEMBL20056118 0.84 CCR2 (0.57) CACNA1IKCNH2HDAC6CCR2EPHX2
SCHEMBL4274691 0.83 CACNA1I (0.46) CACNA1IKCNH2CACNA1HCYP2D6TAS1R3
SCHEMBL19112774 0.82 CACNA1I (0.47) CACNA1IKCNH2CACNA1HCYP2D6TAS1R3
SCHEMBL19112915 0.81 EPHX2 (0.52) CACNA1IKCNH2HTR4CCR2EPHX2
SCHEMBL19112806 0.79 CACNA1I (0.50) CACNA1IKCNH2CACNA1HCYP2D6HDAC6
SCHEMBL19113215 0.78 CACNA1I (0.52) CACNA1IKCNH2CACNA1HCYP2D6HTR4
SCHEMBL20056105 0.77 CACNA1I (0.49) CACNA1IKCNH2CACNA1HCYP2D6TAS1R3
SCHEMBL20056421 0.76 CACNA1I (0.48) CACNA1IKCNH2CACNA1HCYP2D6KDM1A
SCHEMBL4274753 0.76 CACNA1I (0.46) CACNA1IKCNH2CACNA1HCYP2D6KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189839-B1 N-PIPERIDINYL ACETAMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS PRAXIS PREC MEDICINES INC (US) 2020-05-20 EP disclosed
EP-2300007-B1 N-PIPERIDINYL ACETAMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS TARO PHARMACEUTICALS INC (CA) 2018-04-18 EP disclosed